Abstract
Orbital retinoblastoma is a potentially fatal disease. It is more prevalent in the developing world where delay in presentation and lack of access to healthcare contribute to poor survival rates. However, with the evolution of a multimodal therapy, the prognosis for survival has improved significantly. The current treatment protocols use a combination of high-dose systemic chemotherapy, followed by appropriate surgery, radiotherapy, and adjuvant chemotherapy. This chapter discusses in detail the clinical spectrum of orbital retinoblastoma, classification and subtypes, evaluation and investigations, strategies for management, and future perspectives.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ellsworth RM. Orbital retinoblastoma. Trans Am Ophthalmol Soc. 1974;72:79–88.
Grabowski EF, Abramson DH. Intraocular and extra ocular retinoblastoma. Hematol Oncol Clin North Am. 1987;1:721–35.
Kao LY, Su WW, Lin YW. Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000. Jpn J Ophthalmol. 2002;46:577–80.
Badhu B, Sah SP, Thakur SK, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol. 2005;33:386–9.
Chawla B, Hasan F, Azad R, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2015;100:172–8.
Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multi-centre report from the Mexican retinoblastoma group. Br J Ophthalmol. 2004;88:1074–7.
Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology. 1989;96:217–22.
Rootman J, Ellsworth RM, Hofbauer J, et al. Orbital extension of retinoblastoma: a clinicopathological study. Can J Ophthalmol. 1978;13:72–80.
Stannard C, Lipper S, Sealy R, et al. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol. 1979;63:560–70.
Schvartzman E, Chantada G, Fandino A, et al. Results of a stage-based approach for the treatment of retinoblastoma. J Clin Oncol. 1996;14:1532–6.
Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol. 2002;47:1–16.
Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987;94:371–7.
Kauffman EC, Robinson VL, Stadler WM, et al. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol. 2003;169:1122–33.
Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2000;37:134–41.
Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol. 1988;72:576–83.
Chantada G, Doz F, Antoneli CB, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47:801–5.
Chawla B, Kumar K, Singh AD. Influence of socioeconomic and cultural factors on retinoblastoma management. Asia Pac J Oncol Nurs. 2017;4:187–90.
Shields JA, Shields CL. Intraocular tumours: a text and atlas. Philadelphia: WB Saunders; 1992.
Doz F, Khelfaoui F, Mosseri V, et al. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients. Cancer. 1994;74:722–32.
Antoneli CB, Steinhorst F, de Cássia Braga Ribeiro K, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98:1292–8.
Menon BS, Reddy SC, Maziah WM, et al. Extraocular retinoblastoma. Med Pediatr Oncol. 2000;35:75–6.
Honavar SG, Manjandavida FP, Reddy VP. Orbital retinoblastoma: an update. Indian J Ophthalmol. 2017;65:435–42.
Chawla B, Seth R, Moksha L. Chemotherapy for ocular cancers. In: Pharmacology of ocular therapeutics. Cham: Springer International Publishing; 2016. p. 333–58.
Amin MB, Edge SB, Greene FL, et al. Retinoblastoma. In: AJCC cancer staging manual, Ch. 68. 8th ed. New York: Springer; 2017. p. 819–31.
Chawla B, Duraipandi K, Sharma S. MRI in retinoblastoma associated orbital cellulitis. Ophthalmology. 2013;120:1308–9.
Hungerford J. Factors influencing metastasis in retinoblastoma. Br J Ophtalmol. 1993;77:541.
Reese AB. Tumors of the eye. New York: Harper and Row; 1963. p. 155–6.
Chawla B, Hada M, Seth R, et al. Trabeculectomy in eyes with unsuspected retinoblastoma. Ophthalmic Genet. 2016;37:437–40.
Vemuganti GK, Honavar SG, John R. Clinicopathological profile of retinoblastoma in Asian Indians. Invest Ophthalmol Vis Sci. 2000;41:790.
Chawla B, Sharma S, Sen S, et al. Correlation between clinical features, MRI and histopathologic findings in retinoblastoma: a prospective study. Ophthalmology. 2012;119:850–6.
Kiratli PO, Kiratli H, Ercan MT. Visualization of orbital retinoblastoma with technetium-99m (V) dimercaptosuccinic acid. Ann Nucl Med. 1998;12:157–9.
Moll AC, Hoekstra OS, Imhof SM, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Ophthalmic Genet. 2004;25:31–5.
Honavar SG, Singh AD. Management of advanced retinoblastoma. Ophthalmol Clin North Am. 2005;18:65–73.
White L. Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol. 1991;13:189–201.
Goble RR, McKenzie J, Kingston JE, et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol. 1990;74:97–8.
Chawla B, Hasan F, Seth R, et al. Multimodal therapy for stage III retinoblastoma (International Retinoblastoma Staging System). Ophthalmology. 2016;123:1933–9.
Chawla B, Khurana S, Sen S, et al. Clinical misdiagnosis of retinoblastoma in Indian children. Br J Ophthalmol. 2014;98:488–93.
Kim JW, Kathpalia V, Dunkel IJ, et al. Orbital recurrence of retinoblastoma following enucleation. Br J Ophthalmol. 2009;93:463–7.
Kremens B, Wieland R, Rienhart H, et al. High dose chemotherapy with autologous stem cell in children with retinoblastoma. Bone Marrow Transplant. 2003;31:281–4.
Lee SH, Yoo KH, Sung KW, et al. Tandem high-dose chemotherapy and autologous stem cell rescue in children with bilateral advanced retinoblastoma. Bone Marrow Transplant. 2008;42:385–91.
Munier FL, Verwey J, Pica A, et al. New developments in external beam radiotherapy in retinoblastoma from lens to normal tissue-sparing techniques. Clin Exp Ophthalmol. 2008;36:78–89.
Maat-Kievit JA, Oepkes D, Hartwing NG. A large retinoblastoma detected in a fetus at 21 weeks of gestation. Prenat Diagn. 1993;13:377–84.
Salim A, Wiknjosastro GH, Danukusumo D. Fetal retinoblastoma. J Ultrasound Med. 1998;17:717–20.
Parsam VL, Kannabiran C, Honavar SG, et al. A comprehensive, sensitive and economical approach for the detection of mutations in RB1 gene in retinoblastoma. J Genet. 2009;88:517–27.
Chawla B, Singh R. Recent advances and challenges in the management of retinoblastoma. Ind J Ophthalmol. 2017;65:133–9.
Wolff JA, Boesel C, Ellsworth RM, et al. Children’s Cancer Study Group Protocol CCSG 962. New York: Childrens Cancer Group; 1978.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chawla, B., Hada, M. (2019). Orbital Retinoblastoma: Diagnosis and Management. In: Berry, J., Kim, J., Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-11123-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-11123-6_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11122-9
Online ISBN: 978-3-030-11123-6
eBook Packages: MedicineMedicine (R0)